Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Tian

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Hepatology (Baltimore, Md.)|July 7, 2021
Fatty Acid Synthase-Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLDYufeng Hu, Wenzhi He, Yongping Huang, et al.
Clinical and Molecular Hepatology|March 18, 2026
Inactivating LATS2 Variation Drives Tumor Progression and Resistance to Anti-PD-1 Therapy in Intrahepatic CholangiocarcinomaYe Xu, Kai-Xuan Liu, Xin-Yu Wang, et al.
Hepatology (Baltimore, Md.)|April 24, 2021
Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLDXia Yang, Dating Sun, Hui Xiang, et al.
Journal of the American Chemical Society|July 11, 2025
Biomimetic Sandwich-Structured Tubular Ion Pump Arrays for Lithium Metal BatteriesShang-Qi Li, Zhenzhen Wang, Xiaoyang Zheng, et al.
Cancer Research|February 24, 2025
The Glycosyltransferase XYLT1 Activates NF-κB Signaling to Promote Metastasis of Early-Stage Lung AdenocarcinomaJian Han, Jianan Du, Xiangmeng Li, et al.
Journal of Translational Medicine|October 11, 2025
Proteomic insights into platelet dysregulation and pathogenic mechanisms of chronic thromboembolic pulmonary hypertensionLu Sun, Haobo Li, Yuhan Li, et al.
Cell Metabolism|June 9, 2021
TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic diseaseGuang-Nian Zhao, Zheng-Wei Tian, Tian Tian, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2026
Development and Characterization of a Novel Chronic Thromboembolic Pulmonary Hypertension Rat Model: Identifying Sell-Podxl as Potential RegulatorsJixiang Liu, Lin Hou, Jie Yang, et al.
Journal of Hematology & Oncology|May 13, 2017
Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trialMei-Feng Li, Xiao-Li Li, Kai-Liang Fan, et al.
Nature Communications|May 12, 2021
An RFC4/Notch1 signaling feedback loop promotes NSCLC metastasis and stemnessLei Liu, Tianyu Tao, Shihua Liu, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|July 7, 2021
Fatty Acid Synthase-Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLDYufeng Hu, Wenzhi He, Yongping Huang, et al.
Clinical and Molecular Hepatology|March 18, 2026
Inactivating LATS2 Variation Drives Tumor Progression and Resistance to Anti-PD-1 Therapy in Intrahepatic CholangiocarcinomaYe Xu, Kai-Xuan Liu, Xin-Yu Wang, et al.
Hepatology (Baltimore, Md.)|April 24, 2021
Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLDXia Yang, Dating Sun, Hui Xiang, et al.
Journal of the American Chemical Society|July 11, 2025
Biomimetic Sandwich-Structured Tubular Ion Pump Arrays for Lithium Metal BatteriesShang-Qi Li, Zhenzhen Wang, Xiaoyang Zheng, et al.
Cancer Research|February 24, 2025
The Glycosyltransferase XYLT1 Activates NF-κB Signaling to Promote Metastasis of Early-Stage Lung AdenocarcinomaJian Han, Jianan Du, Xiangmeng Li, et al.
Journal of Translational Medicine|October 11, 2025
Proteomic insights into platelet dysregulation and pathogenic mechanisms of chronic thromboembolic pulmonary hypertensionLu Sun, Haobo Li, Yuhan Li, et al.
Cell Metabolism|June 9, 2021
TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic diseaseGuang-Nian Zhao, Zheng-Wei Tian, Tian Tian, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2026
Development and Characterization of a Novel Chronic Thromboembolic Pulmonary Hypertension Rat Model: Identifying Sell-Podxl as Potential RegulatorsJixiang Liu, Lin Hou, Jie Yang, et al.
Journal of Hematology & Oncology|May 13, 2017
Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trialMei-Feng Li, Xiao-Li Li, Kai-Liang Fan, et al.
Nature Communications|May 12, 2021
An RFC4/Notch1 signaling feedback loop promotes NSCLC metastasis and stemnessLei Liu, Tianyu Tao, Shihua Liu, et al.
Pageof 15